Antineoplastic Agents Concept

subject area of

• 2 -Chloro-deoxyadenosine therapy for giant lymph node hyperplasia  Academic Article
• 39·0°C versus 38·5°C ear temperature as fever limit in children with neutropenia undergoing chemotherapy for cancer: a multicentre, cluster-randomised, multiple-crossover, non-inferiority trial  Academic Article
• Erwinia asparaginase after allergy to E. coli asparaginase in children with acute lymphoblastic leukemia  Academic Article
• A Canadian paediatric brain tumour consortium (CPBTC) phase II molecularly targeted study of imatinib in recurrent and refractory paediatric central nervous system tumours  Academic Article
• A Combination of Chemotherapy and Oncolytic Virotherapy Sensitizes Colorectal Adenocarcinoma to Immune Checkpoint Inhibitors in a cDC1-Dependent Manner  Academic Article
• A Multicenter Phase II Clinical Trial of Lapatinib (GW572016) in Hormonally Untreated Advanced Prostate Cancer  Academic Article
• A New Strategy To Improve the Metabolic Stability of Lactone: Discovery of (20S,21S)-21-Fluorocamptothecins as Novel, Hydrolytically Stable Topoisomerase I Inhibitors  Academic Article
• A Phase 1 Study of Mapatumumab (Fully Human Monoclonal Antibody to TRAIL-R1) in Patients with Advanced Solid Malignancies  Academic Article
• A Phase 2 study of perifosine in advanced or metastatic breast cancer  Academic Article
• A Phase I Study of OGX-011, a 2′-Methoxyethyl Phosphorothioate Antisense to Clusterin, in Combination with Docetaxel in Patients with Advanced Cancer  Academic Article
• A Phase I Study of the combination of oxaliplatin/docetaxel and vandetanib for the treatment of advanced gastroesophageal cancer  Academic Article
• A Phase I Trial of Tipifarnib With Radiation Therapy, With and Without Temozolomide, for Patients With Newly Diagnosed Glioblastoma  Academic Article
• A Phase II Trial with Pharmacodynamic Endpoints of the Proteasome Inhibitor Bortezomib in Patients with Metastatic Colorectal Cancer  Academic Article
• A Pilot Study of Hypofractionated Stereotactic Radiation Therapy and Sunitinib in Previously Irradiated Patients With Recurrent High-Grade Glioma  Academic Article
• A Randomized Trial of Letrozole in Postmenopausal Women after Five Years of Tamoxifen Therapy for Early-Stage Breast Cancer  Academic Article
• A Suggested Prognostic Reclassification of Intermediate and Poor-Risk Nonseminomatous Germ Cell Tumors  Academic Article
• A Suggested Prognostic Reclassification of Intermediate and Poor-Risk Nonseminomatous Germ Cell Tumors  Academic Article
• A Time-Trend Economic Analysis of Cancer Drug Trials  Academic Article
• A comparison of patient adherence and preference of packaging method for oral anticancer agents using conventional pill bottles versus daily pill boxes  Academic Article
• A formulary for pediatric oncology in developing countries  Academic Article
• A four gene signature of chromosome instability (CIN4) predicts for benefit from taxanes in the NCIC-CTG MA21 clinical trial  Academic Article
• A mechanistic cohort study evaluating cognitive impairment in women treated for breast cancer  Academic Article
• A multi-method review of home-based chemotherapy  Academic Article
• A multicenter pilot-randomized controlled trial of the feasibility of an augmented red blood cell transfusion strategy for patients treated with induction chemotherapy for acute leukemia or stem cell transplantation  Academic Article
• A multicentric phase II clinical trial on intra-arterial hepatic radiotherapy with 90yttrium SIR-spheres in unresectable, colorectal liver metastases refractory to i.v. chemotherapy: preliminary results on toxicity and response rates.  Academic Article
• A new frontier in treatment of advanced melanoma: Redefining clinical management in the era of immune checkpoint inhibitors  Academic Article
• A new tool to assess bleeding severity in patients with chemotherapy-induced thrombocytopenia (CME)  Academic Article
• A novel stem cell culture model of recurrent glioblastoma  Academic Article
• A novel synthetic C-1 analogue of 7-deoxypancratistatin induces apoptosis in p53 positive and negative human colorectal cancer cells by targeting the mitochondria: enhancement of activity by tamoxifen  Academic Article
• A pharmacodynamic study of the epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 in metastatic colorectal cancer patients.  Academic Article
• A phase 2 study of patupilone in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel: Canadian Urologic Oncology Group study P07a  Conference Paper
• A phase I dose escalation study of the matrix metalloproteinase inhibitor BAY 12-9566 administered orally in patients with advanced solid tumours  Academic Article
• A phase II and pharmacokinetic study of SB-715992, in patients with metastatic hepatocellular carcinoma: a study of the National Cancer Institute of Canada Clinical Trials Group (NCIC CTG IND.168)  Academic Article
• A phase II clinical and pharmacodynamic study of temsirolimus in advanced neuroendocrine carcinomas  Conference Paper
• A phase II study of PS-341 (Bortezomib) in advanced or metastatic urothelial cancer. A trial of the Princess Margaret Hospital and University of Chicago phase II consortia  Academic Article
• A phase II study of SB939, a novel pan-histone deacetylase inhibitor, in patients with translocation-associated recurrent/metastatic sarcomas—NCIC-CTG IND 200  Academic Article
• A phase II study of bortezomib in mantle cell lymphoma: the National Cancer Institute of Canada Clinical Trials Group trial IND.150  Academic Article
• A phase II study of cediranib (AZD 2171) in treatment naive patients with progressive unresectable recurrent or metastatic renal cell carcinoma. A trial of the PMH phase 2 consortium  Academic Article
• A phase II study of ispinesib (SB-715992) in patients with metastatic or recurrent malignant melanoma: a National Cancer Institute of Canada Clinical Trials Group trial  Academic Article
• A phase II study of oral clofazimine in unresectable and metastatic hepatocellular carcinoma  Academic Article
• A phase II study of perifosine (D-21226) in patients with previously untreated metastatic or locally advanced soft tissue sarcoma: A National Cancer Institute of Canada Clinical Trials Group trial  Academic Article
• A phase II study of sorafenib in advanced uterine carcinoma/carcinosarcoma: A trial of the Chicago, PMH, and California Phase II Consortia  Academic Article
• A phase II study of sorafenib in combination with bicalutamide in patients with chemotherapy-naive castration resistant prostate cancer  Academic Article
• A phase II study of sorafenib in patients with chemo-naive castration-resistant prostate cancer  Academic Article
• A phase II study of spirogermanium in patients with metastatic malignant melanoma  Academic Article
• A phase II study of the halichondrin B analog eribulin mesylate in gemcitabine refractory advanced pancreatic cancer  Academic Article
• A phase II trial of ZD1839 (Iressa™) 750 mg per day, an oral epidermal growth factor receptor-tyrosine kinase inhibitor, in patients with metastatic colorectal cancer  Academic Article
• A phase II trial of dacomitinib, an oral pan-human EGF receptor (HER) inhibitor, as first-line treatment in recurrent and/or metastatic squamous-cell carcinoma of the head and neck  Conference Paper
• A phase II trial of dovitinib in previously-treated advanced pleural mesothelioma: The Ontario Clinical Oncology Group  Academic Article
• A phase II trial of sorafenib in first-line metastatic urothelial cancer: a study of the PMH Phase II Consortium  Academic Article
• A phase Ib combination study of RO4929097, a gamma-secretase inhibitor, and temsirolimus in patients with advanced solid tumors  Academic Article
• A polymer-based drug delivery system for the antineoplastic agent bis(maltolato)oxovanadium in mice  Academic Article
• A prognostic factor index for overall survival in patients receiving first-line chemotherapy for HER2-negative advanced breast cancer: An analysis of the ATHENA trial  Academic Article
• A qualitative study evaluating causality attribution for serious adverse events during early phase oncology clinical trials  Academic Article
• A quantitative systems approach to identify paracrine mechanisms that locally suppress immune response to Interleukin-12 in the B16 melanoma model  Academic Article
• A randomized controlled trial comparing standard- and low-dose strategies for transfusion of platelets (SToP) to patients with thrombocytopenia  Academic Article
• A randomized phase II efficacy and safety study of vandetanib (ZD6474) in combination with bicalutamide versus bicalutamide alone in patients with chemotherapy naïve castration-resistant prostate cancer  Academic Article
• A randomized phase II trial of apixaban for the prevention of thromboembolism in patients with metastatic cancer  Academic Article
• A randomized placebo-controlled study of tamoxifen after adjuvant chemotherapy in premenopausal women with early breast cancer (National Cancer Institute of Canada—Clinical Trials Group Trial, MA.12)  Academic Article
• A randomized, double-blind, window of opportunity trial evaluating the effects of chloroquine in breast cancer patients  Academic Article
• A randomized, double-blinded study comparing six doses of batanopride (BMY-25801) with methylprednisolone in patients receiving moderately emetogenic chemotherapy  Academic Article
• A set of NF-κB–regulated microRNAs induces acquired TRAIL resistance in Lung cancer  Academic Article
• A single-institution experience of salvage therapy for patients with early and locally advanced breast cancer who progress during neoadjuvant chemotherapy  Academic Article
• A synthesis of 3-deoxydihydrolycoricidine: Refinement of a structurally minimum pancratistatin pharmacophore  Academic Article
• A systematic review of patient values, preferences and expectations for the treatment of recurrent ovarian cancer  Academic Article
• A target based approach identifies genomic predictors of breast cancer patient response to chemotherapy  Academic Article
• ABT-510 induces tumor cell apoptosis and inhibits ovarian tumor growth in an orthotopic, syngeneic model of epithelial ovarian cancer  Academic Article
• AMP-activated protein kinase (AMPK) beyond metabolism  Academic Article
• Aberrant Epigenetic Regulation: A Central Contributor to Lung Carcinogenesis and a New Therapeutic Target  Academic Article
• Aberrations in Plasma Phospholipid Fatty Acids in Lung Cancer Patients  Academic Article
• Ability of C-reactive protein to complement multiple prognostic classifiers in men with metastatic castration resistant prostate cancer receiving docetaxel-based chemotherapy  Academic Article
• Abrogation of G2 checkpoint specifically sensitize p53 defective cells to cancer chemotherapeutic agents.  Academic Article
• Access to Cytotoxic Medicines by Children With Cancer: A Focus on Low and Middle Income Countries  Academic Article
• Access to essential medicines for children with cancer: a joint SIOP-CCI position statement  Academic Article
• Accounting for reasonableness: Exploring the personal internal framework affecting decisions about cancer drug funding  Academic Article
• Activation of host antitumoral responses by cationic lipid/DNA complexes  Academic Article
• Activity of intravenous menogaril in patients with previously untreated metastatic breast cancer  Academic Article
• Acupuncture Treatment for Chemotherapy-Induced Peripheral Neuropathy – a Case Series  Academic Article
• Addressing adherence to guidelines on prevention of acute chemotherapy‐induced nausea and vomiting in pediatric patients  Conference Paper
• Addressing taxane resistance in metastatic castration-resistant prostate cancer: a focus on chaperone proteins  Academic Article
• Addressing the affordability of cancer drugs: using deliberative public engagement to inform health policy  Academic Article
• Adjunctive therapy (whole body hyperthermia versus lonidamine) to total body irradiation for the treatment of favorable b-cell neoplasms: a report of two pilot clinical trials and laboratory investigations  Academic Article
• Adjuvant Lapatinib and Trastuzumab for Early Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Results From the Randomized Phase III Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization Trial  Academic Article
• Adjuvant chemotherapy for upper-tract urothelial carcinoma treated with nephroureterectomy: Assessment of adequate renal function and influence on outcome  Academic Article
• Adjuvant chemotherapy in colorectal carcinoma  Conference Paper
• Adjuvant radiation therapy, androgen deprivation, and docetaxel for high-risk prostate cancer postprostatectomy: Results of NRG Oncology/RTOG study 0621  Academic Article
• Adjuvant sunitinib following chemoradiotherapy and surgery for locally advanced esophageal cancer: a phase II trial  Academic Article
• Adjuvant therapy and thrombosis: How to avoid the problem?  Academic Article
• Adjuvant therapy for early breast cancer: where do we stand today?  Academic Article
• Adjuvant therapy of the very young woman  Conference Paper
• Adjuvant/neoadjuvant trastuzumab therapy in women with HER-2/neu-overexpressing breast cancer: A systematic review  Academic Article
• Akt isoform specific effects in ovarian cancer progression  Academic Article
• Alemtuzumab and CHOP Chemotherapy for the Treatment of Aggressive Histology Peripheral T Cell Lymphomas: A Multi-Center Phase I Study  Academic Article
• An Endogenous Reactive Oxygen Species (ROS)‐Activated Histone Deacetylase Inhibitor Prodrug for Cancer Chemotherapy  Academic Article
• An Increase in Cellular Size Variance Contributes to the Increase in Ultrasound Backscatter During Cell Death  Academic Article
• An international expanded-access programme of everolimus: Addressing safety and efficacy in patients with metastatic renal cell carcinoma who progress after initial vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapy  Academic Article
• Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels  Academic Article
• Antagonists of the serotonin receptor 5A target human breast tumor initiating cells  Academic Article
• Anticoagulants in cancer  Academic Article
• Antimitotic and cell growth inhibitory properties of combretastatin A-4-like ethers  Academic Article
• Antineoplastic Agents 491.¹ Synthetic Conversion of Aaptamine to Isoaaptamine, 9-Demethylaaptamine, and 4-Methylaaptamine  Academic Article
• Antineoplastic Agents. 362. Isolation and X-ray Crystal Structure of Dibromophakellstatin from the Indian Ocean Sponge Phakellia mauritiana  Academic Article
• Antineoplastic Agents. 380. Isolation and X-ray Crystal Structure Determination of Isoaaptamine from the Republic of Singapore Hymeniacidon sp. and Conversion to the Phosphate Prodrug Hystatin 1  Academic Article
• Antitumor effects of a refined polysaccharide peptide fraction isolated from Coriolus versicolor: in vitro and in vivo studies.  Academic Article
• Antitumor effects of curcumin, alone or in combination with cisplatin or doxorubicin, on human hepatic cancer cells. Analysis of their possible relationship to changes in NF-kB activation levels and in IAP gene expression  Academic Article
• Apixaban to Prevent Venous Thromboembolism in Patients with Cancer  Academic Article
• Application of the systematic review and bibliometric network analysis (SeBriNA) methodology contextualizes evidence. Part 2: rituximab for non-Hodgkin's lymphoma  Academic Article
• Approach to evaluation of fever in ambulatory cancer patients receiving chemotherapy: A systematic review  Academic Article
• Are health states 'timeless'? A case study of an acute condition: post-chemotherapy nausea and vomiting1  Conference Paper
• Are heparins anti-neoplastic agents?  Academic Article
• Assessment of Alectinib vs Ceritinib in ALK-Positive Non–Small Cell Lung Cancer in Phase 2 Trials and in Real-world Data  Academic Article
• Association Between RECIST Changes and Survival in Patients with Metastatic Castration-resistant Prostate Cancer Receiving Docetaxel  Academic Article
• Association between progression-free survival and health-related quality of life in oncology: a systematic review protocol  Academic Article
• Association of Supporting Trial Evidence and Reimbursement for Off-Label Use of Cancer Drugs  Academic Article
• Association of Urine Platinum With Acute Kidney Injury in Children Treated With Cisplatin for Cancer  Academic Article
• Assumptions of Expected Benefits in Randomized Phase III Trials Evaluating Systemic Treatments for Cancer  Academic Article
• Atropine and Roscovitine Release from Model Silicone Hydrogels  Academic Article
• Atypical Lone Pair–π Interaction with Quinone Methides in a Series of Imido‐Ferrociphenol Anticancer Drug Candidates  Academic Article
• Atypical McMurry Cross-Coupling Reactions Leading to a New Series of Potent Antiproliferative Compounds Bearing the Key [Ferrocenyl-Ene-Phenol] Motif  Academic Article
• Audiological monitoring in Swiss childhood cancer patients  Academic Article
• Autoantibodies against the cell surface–associated chaperone GRP78 stimulate tumor growth via tissue factor  Academic Article
• Autologous and Allogeneic Stem-Cell Transplantation for Transformed Follicular Lymphoma: A Report of the Canadian Blood and Marrow Transplant Group  Academic Article
• BAY 43-9006: Early Clinical Data in Patients with Advanced Solid Malignancies  Academic Article
• BDNF and PDE4, but not the GRPR, Regulate Viability of Human Medulloblastoma Cells  Academic Article
• Bench-to-bedside research and the human tumor stem-cell assay--bridging the credibility gap.  Academic Article
• Benzodiazepine-induced inhibition of human malignant melanoma (M-6) cell growth.  Academic Article
• Better Treatments That Cost More: The Dilemma  Academic Article
• Biased Evaluation in Cancer Drug Trials—How Use of Progression-Free Survival as the Primary End Point Can Mislead  Academic Article
• Bim escapes displacement by BH3-mimetic anti-cancer drugs by double-bolt locking both Bcl-XL and Bcl-2  Academic Article
• Biochip arrays for the discovery of a biomarker surrogate in a phase I/II study assessing a novel anti-metastasis agent  Academic Article
• Blood lipid profiles in children with acute lymphoblastic leukemia  Academic Article
• Body Composition as an Independent Determinant of 5-Fluorouracil–Based Chemotherapy Toxicity  Academic Article
• Body composition in long‐term survivors of acute lymphoblastic leukemia diagnosed in childhood and adolescence: A focus on sarcopenic obesity  Academic Article
• Body composition in patients with non−small cell lung cancer: a contemporary view of cancer cachexia with the use of computed tomography image analysis  Academic Article
• Bone Health and Bone-targeted Therapies for Prostate Cancer: a Programme in Evidence-based Care — Cancer Care Ontario Clinical Practice Guideline  Academic Article
• Bone Metastases as the Only Metastatic Site in Patients With Urothelial Carcinoma: Focus on a Special Patient Population  Academic Article
• Bone Turnover Markers as Predictors of Skeletal Complications in Prostate Cancer, Lung Cancer, and Other Solid Tumors  Academic Article
• Bone and mineral abnormalities in childhood acute lymphoblastic leukemia: Influence of disease, drugs and nutrition  Academic Article
• Bone-Targeted Therapy in Early Breast Cancer.  Academic Article
• Bortezomib in Multiple Myeloma: A Practice Guideline  Academic Article
• Bortezomib in Relapsed or Refractory Waldenström's Macroglobulinemia  Academic Article
• Breast cancer chemotherapy induces the release of cell‐free DNA, a novel procoagulant stimulus  Academic Article
• Brief Report: A Phase II Study of Sunitinib in Malignant Pleural Mesothelioma. The NCIC Clinical Trials Group  Academic Article
• Butein impairs the protumorigenic activity of malignant pleural mesothelioma cells  Academic Article
• CNS Prophylaxis and Treatment in Non-Hodgkin's Lymphoma: Variation in Practice and Lessons from the Literature  Academic Article
• CT assessment of tumour response to treatment: comparison of linear, cross-sectional and volumetric measures of tumour size.  Academic Article
• Cabozantinib for Progressive Metastatic Castration-resistant Prostate Cancer Following Docetaxel: Combined Analysis of Two Phase 3 Trials  Academic Article
• Campath-1H Treatment of T-Cell Prolymphocytic Leukemia in Patients for Whom at Least One Prior Chemotherapy Regimen Has Failed  Academic Article
• Canadian Cancer Trials Group IND197: a phase II study of foretinib in patients with estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2-negative recurrent or metastatic breast cancer  Academic Article
• Canadian Perspectives: Update on Inhibition of ALK-Positive Tumours in Advanced Non-Small-Cell Lung Cancer  Academic Article
• Canadian consensus statement on the management of radioactive iodine–resistant differentiated thyroid cancer  Academic Article
• Cancer Care Ontario's New Drug Funding Program: controlled introduction of expensive anticancer drugs.  Academic Article
• Cancer Cell Mitochondria Targeting by Pancratistatin Analogs is Dependent on Functional Complex II and III  Academic Article
• Cancer and Tumor-Associated Childhood Stroke: Results From the International Pediatric Stroke Study  Academic Article
• Cancer predisposition syndromes as a risk factor for early second primary neoplasms after childhood cancer – A national cohort study  Academic Article
• Cancer-Induced Oxidative Stress and Pain  Academic Article
• Cancer-associated bone disease  Academic Article
• Cardiac Outcomes in Pregnant Women With Treated Cancer  Academic Article
• Cardiovascular Risk in Men with Prostate Cancer: Insights from the RADICAL PC Study  Academic Article
• Cardiovascular events in chronic myeloid leukemia clinical trials. Is it time to reassess and report the events according to cardiology guidelines?  Academic Article
• Cardiovascular toxicities of BCR-ABL tyrosine kinase inhibitors in chronic myeloid leukemia: preventive strategies and cardiovascular surveillance  Academic Article
• Carryover and the Two-Period Crossover Clinical Trial  Academic Article
• Causes of reversible nephrogenic diabetes insipidus: A systematic review  Academic Article
• Cell Permeating Nano-Complexes of Amphiphilic Polyelectrolytes Enhance Solubility, Stability, and Anti-Cancer Efficacy of Curcumin  Academic Article
• Cervical cancer in the older woman  Academic Article
• Cetuximab in Metastatic Squamous Cell Cancer of the Skin: A Swiss Case Series  Academic Article
• Changes in Liver Volume Observed Following Sorafenib and Liver Radiation Therapy  Academic Article
• Changes in mitochondrial mass, membrane potential, and cellular adenosine triphosphate content during the cell cycle of human leukemic (HL-60) cells  Academic Article
• Changes in plasma hormones and heart rate variability in patients receiving the cardiotoxic anti-cancer agent bevacizumab  Academic Article
• Characterisation of the lung toxicity of the cell cycle inhibitor temsirolimus  Academic Article
• Characteristics and interpretation of subgroup analyses based on tumour characteristics in randomised trials testing target-specific anticancer drugs: design of a systematic survey  Academic Article
• Characterization of a new cancer-associated mutant of p53 with a missense mutation (K351N) in the tetramerization domain  Academic Article
• Characterization of atrial fibrillation adverse events reported in ibrutinib randomized controlled registration trials  Academic Article
• Checking it twice: an evaluation of checklists for detecting medication errors at the bedside using a chemotherapy model  Academic Article
• Chemotherapy agents and the induction of late lethal defects.  Academic Article
• Chemotherapy and endocrine therapy in metastatic disease.  Academic Article
• Chemotherapy enhances endothelial cell reactivity to platelets  Academic Article
• Chemotherapy for recurrent epithelial ovarian cancer previously treated with platinum--a systematic review of the evidence from randomized trials.  Academic Article
• Chemotherapy of advanced ovarian carcinoma: Initial experience using a platinum-based combination  Academic Article
• Chemotherapy-Induced Neuropathy and Drug Discovery Platform Using Human Sensory Neurons Converted Directly from Adult Peripheral Blood  Academic Article
• Chemotherapy-Induced Toxicities: An Imaging Primer  Academic Article
• Children Receiving Chemotherapy at Home: Perceptions of Children and Parents  Academic Article
• Children who receive antineoplastic treatment may be more likely to develop dental defects  Academic Article
• Cisplatin-Based First-Line Therapy for Advanced Urothelial Carcinoma After Previous Perioperative Cisplatin-Based Therapy  Academic Article
• Classification of the acute emetogenicity of chemotherapy in pediatric patients: A clinical practice guideline  Academic Article
• Clinical Outcomes and Adverse Events after First-Line Treatment in Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-Analysis  Academic Article
• Clinical Practice Guidelines in Cardio-Oncology  Academic Article
• Clinical Trial Evidence Supporting US Food and Drug Administration Approval of Novel Cancer Therapies Between 2000 and 2016  Academic Article
• Clinical and toxicity predictors of response and progression to temsirolimus in women with recurrent or metastatic endometrial cancer  Academic Article
• Clinical benefit of glasdegib plus low-dose cytarabine in patients with de novo and secondary acute myeloid leukemia: long-term analysis of a phase II randomized trial  Academic Article
• Clinical outcome following post-chemotherapy retroperitoneal lymph node dissection in men with intermediate- and poor-risk nonseminomatous germ cell tumour  Academic Article
• Clinical practice guidelines for the care and treatment of breast cancer: follow-up after treatment for breast cancer (summary of the 2005 update)  Academic Article
• Combined gamma‐irradiation and subsequent cisplatin treatment in human squamous carcinoma cell lines sensitive and resistant to cisplatin  Academic Article
• Combined therapy with thrombospondin‐1 type I repeats (3TSR) and chemotherapy induces regression and significandy improves survival in a preclinical model of advanced stage epithelial ovarian cancer  Academic Article
• Combining Oncolytic HSV-1 with Immunogenic Cell Death-Inducing Drug Mitoxantrone Breaks Cancer Immune Tolerance and Improves Therapeutic Efficacy  Academic Article
• Commentary: Anthracyclines in Early-Stage Breast Cancer: Is It the End of an Era?  Academic Article
• Comparative safety and effectiveness of serotonin receptor antagonists in patients undergoing chemotherapy: a systematic review and network meta-analysis  Academic Article
• Comparison of the mutagenic responses of 12 anticancer drugs at the hypoxanthine-guanine phosphoribosyl transferase and adenosine kinase loci in chinese hamster ovary cells  Academic Article
• Compound Kushen Injection suppresses human breast cancer stem-like cells by down-regulating the canonical Wnt/β-catenin pathway  Academic Article
• Conference abstracts of a new oncology drug do not always lead to full publication: Proceed with caution  Academic Article
• Continuous low-dose anti-angiogenic/metronomic chemotherapy: from the research laboratory into the oncologyclinic  Academic Article
• Contrasting evidence to reimbursement reality for off-label use (OLU) of drug treatments in cancer care: rationale and design of the CEIT-OLU project  Academic Article
• Controlling angiogenesis in breast cancer: A systematic review of anti-angiogenic trials  Academic Article
• Coping with uncertainty: T1a,bN0M0 HER2-positive breast cancer, do we have a treatment threshold?  Academic Article
• Coronary artery disease surveillance among childhood, adolescent and young adult cancer survivors: A systematic review and recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization Group  Academic Article
• Cost Effectiveness of EML4-ALK Fusion Testing and First-Line Crizotinib Treatment for Patients With Advanced ALK-Positive Non–Small-Cell Lung Cancer  Academic Article
• Cost effectiveness of outpatient treatment for febrile neutropaenia in adult cancer patients  Academic Article
• Cost-Effectiveness of Osimertinib in Treating Newly Diagnosed, Advanced EGFR-Mutation-Positive Non-Small Cell Lung Cancer  Academic Article
• Cross resistance pattern towards anticancer drugs of a human carcinoma multidrug-resistant cell line  Academic Article
• Current Incidence and Outcomes of Gastrointestinal Mesenchymal Tumors Including Gastrointestinal Stromal Tumors  Academic Article
• Current Issues in Cancer Management of carcinomas of the upper gastrointestinal tract  Academic Article
• Current management of actinic keratoses.  Academic Article
• Cysteine-Rich Protein Reverses Weight Loss in Lung Cancer Patients Receiving Chemotherapy or Radiotherapy  Academic Article
• Cytokines oncostatin M and interleukin 1 regulate the expression of the IL-6 receptor (gp80, gp130)  Academic Article
• DIFFERENTIAL SENSITIVITY TO SHORT-CHAIN CERAMIDE ANALOGUES OF HUMAN INTESTINAL CARCINOMA CELLS GROWN IN TUMOR SPHEROIDS VERSUS MONOLAYER CULTURE  Academic Article
• Daratumumab in newly diagnosed MM — incorporating lessons learnt from CASSIOPEIA, MAIA and beyond  Academic Article
• De novo necroptosis creates an inflammatory environment mediating tumor susceptibility to immune checkpoint inhibitors  Academic Article
• De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017  Academic Article
• Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non‐surgical patients  Academic Article
• Deptor transcriptionally regulates endoplasmic reticulum homeostasis in multiple myeloma cells  Academic Article
• Design Considerations in Crossover Trials with a Single Interim Analysis and Serial Patient Entry  Academic Article
• Design, synthesis and biological activity of piperlongumine derivatives as selective anticancer agents  Academic Article
• Design, synthesis and biological evaluation of di-substituted noscapine analogs as potent and microtubule-targeted anticancer agents  Academic Article
• Detection and monitoring of cardiotoxicity—what does modern cardiology offer?  Conference Paper
• Determining optimal sample sizes for multi-stage randomized clinical trials using value of information methods  Academic Article
• Determining resource intensity weights in ambulatory chemotherapy related to nursing workload  Academic Article
• Development of adapted RECIST criteria to assess response in lymphoma and their comparison to the International Workshop Criteria  Academic Article
• Developments in cancer prevention and treatment using traditional Chinese medicine  Academic Article
• Dexamethasone dosing for prevention of acute chemotherapy‐induced vomiting in pediatric patients: A systematic review  Academic Article
• Dexamethasone improves the efficacy of granisetron in the first 24 h following high-dose cisplatin chemotherapy  Academic Article
• Diabetes and breast cancer among women with BRCA1 and BRCA2 mutations  Academic Article
• Direct anti-cancer effect of oncostatin M on chondrosarcoma  Academic Article
• Discovery of 1-arylpyrrolidone derivatives as potent p53–MDM2 inhibitors based on molecule fusing strategy  Academic Article
• Discovery of HDAC6-Selective Inhibitor NN-390 with in Vitro Efficacy in Group 3 Medulloblastoma  Academic Article
• Discovery of a novel class of aldol-derived 1,2,3-triazoles: Potent and selective inhibitors of human cytochrome P450 19A1 (aromatase)  Academic Article
• Diversity-oriented synthesis and bioactivity evaluation of N-substituted ferrocifen compounds as novel antiproliferative agents against TNBC cancer cells  Academic Article
• Domains of Structured Oral Anticancer Medication Programs: A Scoping Review  Academic Article
• Double-blind randomised trial of very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancer  Academic Article
• Doxorubicin administration by continuous infusion is not cardioprotective: the Dana-Farber 91-01 Acute Lymphoblastic Leukemia protocol.  Academic Article
• Drug evaluation: AP-23573--an mTOR inhibitor for the treatment of cancer.  Academic Article
• Drugs targeting Bcl-2 family members as an emerging strategy in cancer  Academic Article
• Durable remission of both multicentric Castleman's disease and Kaposi's sarcoma with valganciclovir, rituximab and liposomal doxorubicin in an HHV-8-positive, HIV-negative patient  Academic Article
• Duration of letrozole treatment and outcomes in the placebo-controlled NCIC CTG MA.17 extended adjuvant therapy trial  Academic Article
• Dynamic Contrast-Enhanced Magnetic Resonance Imaging of Vascular Changes Induced by Sunitinib in Papillary Renal Cell Carcinoma Xenograft Tumors  Academic Article
• EPIDERMAL GROWTH FACTOR-MEDIATED ACTIVATION OF THE MAP KINASE CASCADE RESULTS IN ALTERED EXPRESSION AND FUNCTION OF ABCG2 (BCRP)  Academic Article
• Early tumor shrinkage is independently associated with improved overall survival among patients with metastatic renal cell carcinoma: a validation study using the COMPARZ cohort  Academic Article
• Early‐stage Hodgkin lymphoma in the modern era: simulation modelling to delineate long‐term patient outcomes  Academic Article
• Economic evaluation of nivolumab for the treatment of second-line advanced squamous NSCLC in Canada: a comparison of modeling approaches to estimate and extrapolate survival outcomes  Academic Article
• Editorial Comment on: Metastin Inhibits Migration and Invasion of Renal Cell Carcinoma with Overexpression of Metastin Receptor  Academic Article
• Educational Paper: Decreasing the burden of cardiovascular disease in childhood cancer survivors: An update for the pediatrician  Academic Article
• Effect of Everolimus on Bone Marker Levels and Progressive Disease in Bone in BOLERO-2  Academic Article
• Effect of Herceptin on the development and progression of skeletal metastases in a xenograft model of human breast cancer  Academic Article
• Effect of Letrozole Versus Placebo on Bone Mineral Density in Women With Primary Breast Cancer Completing 5 or More Years of Adjuvant Tamoxifen: A Companion Study to NCIC CTG MA.17  Academic Article
• Effect of Metformin vs Placebo on Invasive Disease–Free Survival in Patients With Breast Cancer  Academic Article
• Effect of aerobic exercise on cancer‐associated cognitive impairment: A proof‐of‐concept RCT  Academic Article
• Effect of radiation and other cytotoxic agents on the growth of cells cultured from normal and tumor tissues from the female genital tract  Academic Article
• Effects of Adjuvant Tamoxifen and of Cytotoxic Therapy on Mortality in Early Breast Cancer  Academic Article
• Effects of Antimicrobial and Antineoplastic Drugs on the Phagocytic and Microbicidal Function of the Polymorphonuclear Leukocyte  Academic Article
• Effects of Intravenously Administered Recombinant Vesicular Stomatitis Virus (VSV ΔM51 ) on Multifocal and Invasive Gliomas  Academic Article
• Effects of Sweet Bee Venom Pharmacopuncture Treatment for Chemotherapy-Induced Peripheral Neuropathy  Academic Article
• Effects of antimitotic and antimitochondrial agents on the cellular distribution of microtubules and mitochondria.  Academic Article
• Effects of metformin versus placebo on vitamin B12 metabolism in non-diabetic breast cancer patients in CCTG MA.32  Academic Article
• Efficacy and Safety of Gemcitabine Plus Either Taxane or Carboplatin in the First-Line Setting of Metastatic Urothelial Carcinoma: A Systematic Review and Meta-Analysis  Academic Article
• Efficacy, Toxicity, and Quality of Life in Older Women With Early-Stage Breast Cancer Treated With Letrozole or Placebo After 5 Years of Tamoxifen: NCIC CTG Intergroup Trial MA.17  Academic Article
• Emerging Biomarker-Guided Therapies in Prostate Cancer  Academic Article
• Enantioselective Synthesis of Planar Chiral Ferrocifens that Show Chiral Discrimination in Antiproliferative Activity on Breast Cancer Cells  Academic Article
• Endoplasmic Reticulum Chaperone Protein GRP78 Protects Cells from Apoptosis Induced by Topoisomerase Inhibitors  Academic Article
• Epidermal Growth Factor Receptor: Pathway, Therapies, and Pipeline  Academic Article
• Erythrocytotoxicity Induced by Cancer Chemotherapeutic Agents  Academic Article
• Erythropoiesis-stimulating agents (ESAs): Do they still have a role in chemotherapy-induced anemia (CIA)?  Academic Article
• Erythropoietin in the management of patients with nonhematologic cancer receiving chemotherapy. Systemic Treatment Program Committee.  Academic Article
• Esophageal gastrointestinal stromal tumor: report of 7 patients  Academic Article
• Essential medicines for cancer: WHO recommendations and national priorities  Academic Article
• Essential medicines for childhood cancer in Europe: a pan-European, systematic analysis by SIOPE  Academic Article
• Essential medicines for children with cancer  Academic Article
• Essential medicines for pediatric oncology in developing countries  Academic Article
• Estrogen independent gene expression defines clinically relevant subgroups of estrogen receptor positive breast cancer  Academic Article
• Estrogen receptor: is it predictive for response to cytotoxic as well as hormonal therapy?  Academic Article
• European oncologists' preferences for the management of breast cancer: case presentations and expert commentary  Academic Article
• Evaluating Treatments for Childhood Cancer: A Process for Critical Appraisal of the Literature and a Summary of the Results  Academic Article
• Evaluation of Adverse Events Experienced by Older Patients Participating in Studies of Molecularly Targeted Agents Alone or in Combination  Academic Article
• Evaluation of Cognitive Function Associated With Chemotherapy: A Review of Published Studies and Recommendations for Future Research  Conference Paper
• Evaluation of metformin in early breast cancer: a modification of the traditional paradigm for clinical testing of anti-cancer agents  Academic Article
• Evidence for a dose-response effect between p53 (but not p21WAF1/Cip1) protein concentrations, survival, and responsiveness in patients with epithelial ovarian cancer treated with platinum-based chemotherapy.  Conference Paper
• Exacerbation of coagulopathy with concurrent bone marrow necrosis, hepatic and renal dysfunction secondary to all-trans retinoic acid therapy for acute promyelocytic leukemia  Academic Article
• Experience with ponatinib in paediatric patients with leukaemia  Academic Article
• Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging  Academic Article
• Expression of delayed toxicity and lethal mutations in the progeny of human cells surviving exposure to radiation and other environmental mutagens  Conference Paper
• Expression of survivin and p16INK4a/Cdk6/pRB proteins and induction of apoptosis in response to radiation and cisplatin in meningioma cells  Academic Article
• FEASIBILITY AND SAFETY OF FULL DOSE ANTICOAGULATION THERAPY (ACT) IN CHILDREN TREATED ACCORDING TO DANA-FARBER CANCER INSTITUTE (DFCI) ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) CONSORTIUM THERAPY PROTOCOLS  Conference Paper
• Facile Construction of Structurally Diverse Thiazolidinedione-Derived Compounds via Divergent Stereoselective Cascade Organocatalysis and Their Biological Exploratory Studies  Academic Article
• Fair, just and compassionate: A pilot for making allocation decisions for patients requesting experimental drugs outside of clinical trials  Academic Article
• Feasibility and safety of delivering full‐dose anticoagulation therapy in children treated according to Dana‐Farber Cancer Institute acute lymphoblastic leukemia consortium therapy protocols  Academic Article
• Feasibility of real time next generation sequencing of cancer genes linked to drug response: Results from a clinical trial  Academic Article
• Fieber bei chemotherapie-assoziierter Neutropenie  Academic Article
• First-Line Bevacizumab-Containing Therapy for Triple-Negative Breast Cancer: Analysis of 585 Patients Treated in the ATHENA Study  Academic Article
• First-Line Nivolumab in Stage IV or Recurrent Non–Small-Cell Lung Cancer  Academic Article
• First-in-human phase I study of SOR-C13, a TRPV6 calcium channel inhibitor, in patients with advanced solid tumors  Academic Article
• Flavopiridol Sensitivity of Cancer Cells Isolated from Ascites and Pleural Fluids  Academic Article
• Flavopiridol in Untreated or Relapsed Mantle-Cell Lymphoma: Results of a Phase II Study of the National Cancer Institute of Canada Clinical Trials Group  Academic Article
• Funding New Cancer Drugs in Ontario: Closing the Loop in the Practice Guidelines Development Cycle  Academic Article
• Gain-of-function mutant p53 downregulates miR-223 contributing to chemoresistance of cultured tumor cells  Academic Article
• Gender andBCR-ABLtranscript type are correlated with molecular response to imatinib treatment in patients with chronic myeloid leukemia  Academic Article
• Genome-Wide Associations and Functional Genomic Studies of Musculoskeletal Adverse Events in Women Receiving Aromatase Inhibitors  Academic Article
• Glasgow Prognostic Score As a Prognostic Factor in Metastatic Castration-Resistant Prostate Cancer Treated With Docetaxel-Based Chemotherapy  Academic Article
• Growth and body composition in response to chemotherapy in children with acute lymphoblastic leukemia  Academic Article
• Growth inhibition of prostate cancer xenografts by halofuginone  Academic Article
• Guideline for the classification of the acute emetogenic potential of antineoplastic medication in pediatric cancer patients  Academic Article
• Guideline for the prevention and treatment of anticipatory nausea and vomiting due to chemotherapy in pediatric cancer patients  Academic Article
• Guideline for the prevention of acute nausea and vomiting due to antineoplastic medication in pediatric cancer patients  Academic Article
• Guidelines for vismodegib in the management of periocular basal cell carcinoma  Academic Article
• HDAC inhibitor M344 suppresses MCF-7 breast cancer cell proliferation  Academic Article
• HDACi Delivery Reprograms Tumor-Infiltrating Myeloid Cells to Eliminate Antigen-Loss Variants  Academic Article
• HER-2 and Topoisomerase II As Predictors of Response to Chemotherapy  Academic Article
• HER2 Testing in a Population-Based Study of Patients With Metastatic Breast Cancer Treated With Trastuzumab  Academic Article
• HER2/neu in systemic therapy for women with breast cancer: a systematic review  Academic Article
• HIPK2 neutralizes MDM2 inhibition rescuing p53 transcriptional activity and apoptotic function  Academic Article
• Health related quality of life of women in TEACH, a randomised placebo controlled adjuvant trial of lapatinib in early stage Human Epidermal Growth Factor Receptor (HER2) overexpressing breast cancer  Academic Article
• Health-related quality of life and disease symptoms in postmenopausal women with HR⁺, HER2⁻advanced breast cancer treated with everolimus plus exemestane versus exemestane monotherapy  Academic Article
• Helping Patients Make Informed Choices: A Randomized Trial of a Decision Aid for Adjuvant Chemotherapy in Lymph Node-Negative Breast Cancer  Academic Article
• Heparin/heparan sulfate interacting protein plays a role in apoptosis induced by anticancer drugs  Academic Article
• Heterogeneity among lists of cautioned or prohibited drugs in protocols of early-phase oncology trials  Academic Article
• High-dose chemotherapy with autologous hematopoietic stem-cell support for breast cancer in North America.  Academic Article
• Home chemotherapy for children with cancer: perspectives from health care professionals  Academic Article
• Homocysteine and methylmalonic acid: markers to predict and avoid toxicity from pemetrexed therapy.  Academic Article
• Hospital-acquired infections at an oncological intensive care cancer unit: differences between solid and hematological cancer patients  Academic Article
• How I do it: Prescribing abiraterone acetate for metastatic castration resistant prostate cancer.  Academic Article
• How Variable Is Our Delivery of Information? Approaches to Patient Education About Oral Chemotherapy in the Pediatric Oncology Clinic  Academic Article
• Human cells deficient in transcription-coupled repair show prolonged activation of the Jun N-terminal kinase and increased sensitivity following cisplatin treatment  Academic Article
• Hypercoagulability preceding cancer  Academic Article
• Hypermagnesiuria and Hypercalciuria in Childhood Leukemia  Academic Article
• Hypertension Due to Antiangiogenic Cancer Therapy With VEGF Inhibitors: Is Autonomic Nervous System Toxicity Another Possible Mechanism?  Academic Article
• Identification of Drugs Including a Dopamine Receptor Antagonist that Selectively Target Cancer Stem Cells  Academic Article
• Identification of early breast cancer patient cohorts who may benefit from lapatinib therapy  Academic Article
• Imaging Intratumoral Convection: Pressure-Dependent Enhancement in Chemotherapeutic Delivery to Solid Tumors  Academic Article
• Imatinib Mesylate in Patients With Adenoid Cystic Cancers of the Salivary Glands Expressing c-kit: A Princess Margaret Hospital Phase II Consortium Study  Academic Article
• Imatinib for Melanomas Harboring Mutationally Activated or Amplified KIT Arising on Mucosal, Acral, and Chronically Sun-Damaged Skin  Academic Article
• Imipridone Anticancer Compounds Ectopically Activate the ClpP Protease and Represent a New Scaffold for Antibiotic Development  Academic Article
• Immediate Post–Transurethral Resection of Bladder Tumor Intravesical Chemotherapy Prevents Non–Muscle-invasive Bladder Cancer Recurrences: An Updated Meta-analysis on 2548 Patients and Quality-of-Evidence Review  Academic Article
• Immune-Checkpoint Induced Skin Toxicity Masked as Squamous Cell Carcinoma: Case Report on Mimickers of Dermatological Toxicity with PD-1 Inhibition  Academic Article
• Immuno-Isolation in Oncology - A Mini-Review  Academic Article
• Immunotherapy with rituximab during peripheral blood stem cell transplantation for non-Hodgkin's lymphoma  Academic Article
• Impact and Perceptions of Mandatory Tumor Biopsies for Correlative Studies in Clinical Trials of Novel Anticancer Agents  Conference Paper
• Impact of Prior Platinum-Based Therapy on Patients Receiving Salvage Systemic Treatment for Advanced Urothelial Carcinoma  Academic Article
• Impact of Response to Prior Chemotherapy in Patients With Advanced Urothelial Carcinoma Receiving Second-Line Therapy: Implications for Trial Design  Academic Article
• Impact of a Novel Prioritization Framework on Clinician-Led Oncology Drug Submissions  Academic Article
• Impact of baseline BMI and weight change in CCTG adjuvant breast cancer trials  Academic Article
• Impact of chemotherapy-associated nausea and vomiting on patients' functional status and on costs: survey of five Canadian centres.  Academic Article
• Impact of premenopausal status at breast cancer diagnosis in women entered on the placebo-controlled NCIC CTG MA17 trial of extended adjuvant letrozole  Academic Article
• Improvements in Radiographic Progression-Free Survival Stratified by ERG Gene Status in Metastatic Castration-Resistant Prostate Cancer Patients Treated with Abiraterone Acetate  Academic Article
• In Utero Exposure to Chemotherapy: Effect on Cardiac and Neurologic Outcome  Academic Article
• In vitro antineoplastic effects of brivaracetam and lacosamide on human glioma cells  Academic Article
• In vitro inhibition of proliferation of HL-60 cells by tetrandrine and coriolus versicolor peptide derived from Chinese medicinal herbs  Academic Article
• Incidence of Metastatic Nonseminomatous Germ Cell Tumor Outside the Boundaries of a Modified Postchemotherapy Retroperitoneal Lymph Node Dissection  Academic Article
• Incidence of second primary malignancies in patients with multiple myeloma receiving anti-CD38 monoclonal antibodies: A systematic review and meta-analysis  Academic Article
• Incident Vertebral Fractures in Children With Leukemia During the Four Years Following Diagnosis  Academic Article
• Inconsistency of prognostic factors for post-chemotherapy nausea and vomiting  Academic Article
• Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials  Academic Article
• Incremental net benefit in randomized clinical trials  Academic Article
• Indirect comparison of the efficacy of cetuximab and cisplatin in squamous cell carcinoma of the head and neck  Academic Article
• Induced p53 expression in lung cancer cell line promotes cell senescence and differentially modifies the cytotoxicity of anti-cancer drugs  Academic Article
• Induction chemotherapy with paclitaxel and cisplatin followed by radiotherapy for larynx organ preservation in advanced laryngeal and hypopharyngeal cancer offers moderate late toxicity outcome (DeLOS-I-trial)  Academic Article
• Induction of Mdm2 and enhancement of cell survival by bFGF  Academic Article
• Influence of the proto-oncogene c-fos on cisplatin sensitivity  Academic Article
• Inhibition of p53 Transcriptional Activity by Bcl-2 Requires Its Membrane-anchoring Domain  Academic Article
• Initial Management of Small-Cell Lung Cancer (limited- and Extensive-Stage) and the Role of Thoracic Radiotherapy and First-Line Chemotherapy: A Systematic Review  Academic Article
• Initial characterization of an antineoplastic, polysaccharide-rich extract of Mycobacterium bovis BCG, Tice substrain.  Academic Article
• Initiation of Chemotherapy in Cancer Patients with Poor Performance Status: A Population-Based Analysis  Academic Article
• Innovative uses of imiquimod.  Academic Article
• Integration of Bone and Computed Tomography Scans to Assess Bone Metastasis in Metastatic Castration-Resistant Prostate Cancer  Academic Article
• Intent-to-treat analysis of the placebo-controlled trial of letrozole for extended adjuvant therapy in early breast cancer: NCIC CTG MA.17  Academic Article
• Interactions of doxycycline with chemotherapeutic agents in human breast adenocarcinoma MDA-MB-231 cells  Academic Article
• Interventions for the prevention of acute phase chemotherapy-induced nausea and vomiting in adult and pediatric patients: a systematic review and meta-analysis  Academic Article
• Intraperitoneal chemotherapy in the first-line treatment of women with stage III epithelial ovarian cancer  Academic Article
• Intratumoral heterogeneity: pathways to treatment resistance and relapse in human glioblastoma  Academic Article
• Intravenous PEG-asparaginase during remission induction in children and adolescents with newly diagnosed acute lymphoblastic leukemia  Academic Article
• Intravenous and Oral Itraconazole versus Intravenous Amphotericin B Deoxycholate as Empirical Antifungal Therapy for Persistent Fever in Neutropenic Patients with Cancer Who Are Receiving Broad-Spectrum Antibacterial Therapy  Academic Article
• Intravenous pegylated asparaginase versus intramuscular native Escherichia coli l-asparaginase in newly diagnosed childhood acute lymphoblastic leukaemia (DFCI 05-001): a randomised, open-label phase 3 trial  Academic Article
• Investigating the potential clinical benefit of Selumetinib in resensitising advanced iodine refractory differentiated thyroid cancer to radioiodine therapy (SEL-I-METRY): protocol for a multicentre UK single arm phase II trial  Academic Article
• Involvement of 1,25D3-MARRS (membrane associated, rapid response steroid-binding), a novel vitamin D receptor, in growth inhibition of breast cancer cells  Academic Article
• Is SABR Cost-Effective in Oligometastatic Cancer? An Economic Analysis of the SABR-COMET Randomized Trial  Conference Paper
• Is There a Role for Positron Emission Tomography in Breast Cancer Staging?  Academic Article
• Is There an Economic Rationale for Cancer Drugs to Have a Separate Reimbursement Review Process for Resource Allocation Purposes?  Academic Article
• Isolation and Characterization of Novel Marine-Derived Actinomycete Taxa Rich in Bioactive Metabolites  Academic Article
• Lack of evidence for a role of chemotherapy in the routine management of locally advanced head and neck cancer.  Academic Article
• Large Nontransplanted Hepatocellular Carcinoma in Woodchucks: Treatment With Adenovirus-Mediated Delivery of Interleukin 12/B7.1 Genes  Academic Article
• Late Extended Adjuvant Treatment With Letrozole Improves Outcome in Women With Early-Stage Breast Cancer Who Complete 5 Years of Tamoxifen  Academic Article
• Late effects of high-dose methotrexate treatment in childhood cancer survivors—a systematic review  Academic Article
• Left and right ventricular effects of anthracycline and trastuzumab chemotherapy: A prospective study using novel cardiac imaging and biochemical markers  Academic Article
• Lenalidomide treatment and prognostic markers in relapsed or refractory chronic lymphocytic leukemia: data from the prospective, multicenter phase-II CLL-009 trial  Academic Article
• Lessons learned from the Sunbelt Melanoma Trial  Academic Article
• Leukemia after Chemotherapy for Cancer  Academic Article
• Local tumour control in women with carcinoma of the cervix treated with the addition of nitroimidazole agents to radiotherapy: a meta-analysis  Academic Article
• Location of colon cancer (right-sided versus left-sided) as a prognostic factor and a predictor of benefit from cetuximab in NCIC CO.17  Academic Article
• Long-Term Clinical Outcome After Postchemotherapy Retroperitoneal Lymph Node Dissection in Men With Residual Teratoma  Academic Article
• Long-Term Studies Assessing Outcomes of Ibrutinib Therapy in Patients With Del(11q) Chronic Lymphocytic Leukemia  Academic Article
• Long-term gross motor performance following treatment for acute lymphoblastic leukemia  Academic Article
• Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials  Academic Article
• Lung cancer.  Academic Article
• Lung cancer.  Academic Article
• Lung cancer.  Academic Article
• Major arterial events in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a meta-analysis  Academic Article
• Management of HER2-positive breast cancer in Asia: consensus statement from the Asian Oncology Summit 2009  Academic Article
• Management of advanced or recurrent cervical cancer: chemotherapy and beyond  Academic Article
• Mathematical model for chemotherapeutic drug efficacy in arresting tumour growth based on the cancer stem cell hypothesis  Academic Article
• Measuring the Quality of a Childhood Cancer Care Delivery System: Assessing Stakeholder Agreement  Academic Article
• Mechanism and non-mechanism based imaging biomarkers for assessing biological response to treatment in non-small cell lung cancer  Academic Article
• Mechanism of action of antimitotic drugs: A new hypothesis based on the role of cellular calcium  Academic Article
• Mechanisms of Cardiovascular Toxicity of BCR-ABL1 Tyrosine Kinase Inhibitors in Chronic Myelogenous Leukemia  Academic Article
• Medicines for cancers in children: The WHO model for selection of essential medicines  Academic Article
• Melanoma in children and the use of sentinel lymph node biopsy  Conference Paper
• Melatonin as Adjuvant Cancer Care With and Without Chemotherapy  Academic Article
• Meta-analysis: Effect of Prophylactic Hematopoietic Colony-Stimulating Factors on Mortality and Outcomes of Infection  Academic Article
• Metabolic flexibility determines human NK cell functional fate in the tumor microenvironment  Academic Article
• Metabolic response by FDG-PET to imatinib correlates with exon 11 KIT mutation and predicts outcome in patients with mucosal melanoma  Academic Article
• Metabolomic adaptations and correlates of survival to immune checkpoint blockade  Academic Article
• Metastatic renal cell cancer treatments: An indirect comparison meta-analysis  Academic Article
• Metformin ameliorates arsenic trioxide hepatotoxicity via inhibiting mitochondrial complex I  Academic Article
• Methods to improve the estimation of time‐to‐event outcomes when data is de‐identified  Academic Article
• MicroRNA Signature in Metastatic Colorectal Cancer Patients Treated With Anti-EGFR Monoclonal Antibodies  Academic Article
• Mitochondrial DNA damage by anticancer agents  Academic Article
• Mitochondrial contributions to cancer cell physiology: potential for drug development  Academic Article
• Mitochondrial contributions to cancer cell physiology: redox balance, cell cycle, and drug resistance.  Academic Article
• Mixed Variant Multicentric Castleman Disease Treated With Rituximab: Case Report  Academic Article
• Modulation of goldfish testicular testosterone production in vitro by tumor necrosis factor ?, interleukin-1?, and macrophage conditioned media  Academic Article
• Monoamine oxidase inhibitors l-deprenyl and clorgyline protect nonmalignant human cells from ionising radiation and chemotherapy toxicity  Academic Article
• Motexafin Gadolinium Combined With Prompt Whole Brain Radiotherapy Prolongs Time to Neurologic Progression in Non–Small-Cell Lung Cancer Patients With Brain Metastases: Results of a Phase III Trial  Academic Article
• Mould-active compared with fluconazole prophylaxis to prevent invasive fungal diseases in cancer patients receiving chemotherapy or haematopoietic stem-cell transplantation: a systematic review and meta-analysis of randomised controlled trials  Academic Article
• Moving promising research findings to the clinic: Methodological issues in the design and conduct of clinical trials of retinoids  Academic Article
• Multitargeted Antifolate LY231514 as First-Line Chemotherapy for Patients With Advanced Non–Small-Cell Lung Cancer: A Phase II Study  Academic Article
• Multitargeted anti-angiogenic agents and NSCLC: Clinical update and future directions  Academic Article
• Multitargeting activity of miR-24 inhibits long-term melatonin anticancer effects  Academic Article
• Muscle atrophy in cancer: a role for nutrition and exercise  Academic Article
• Mutant p53 gain of function: differential effects of different p53 mutants on resistance of cultured cells to chemotherapy  Academic Article
• Naturally occurring resistance of bone marrow mononuclear and metastatic cancer cells to anticancer agents  Academic Article
• Neurite outgrowth in PC12 cells is enhanced by guanosine through both cAMP-dependent and -independent mechanisms  Academic Article
• Neuropsychological outcomes of a randomized trial of prednisone versus dexamethasone in acute lymphoblastic leukemia: Findings from Dana-Farber Cancer Institute All Consortium Protocol 00-01  Academic Article
• New onset vasomotor symptoms but not musculoskeletal symptoms associate with clinical outcomes on extended adjuvant letrozole – Analyses from NCIC CTG MA.17  Academic Article
• Next Wave of Targets in the Treatment of Advanced Renal Cell Carcinoma  Academic Article
• Nitric oxide and anti-cancer therapy  Academic Article
• Nivolumab Monotherapy for First-Line Treatment of Advanced Non–Small-Cell Lung Cancer  Academic Article
• No. 370-Management of Squamous Cell Cancer of the Vulva  Academic Article
• Non-hormonal systemic therapy in men with hormone-refractory prostate cancer and metastases: a systematic review from the Cancer Care Ontario Program in Evidence-based Care's Genitourinary Cancer Disease Site Group  Academic Article
• Non-melanoma Skin Cancer in Canada Chapter 3: Management of Actinic Keratoses  Academic Article
• Noninvasive molecular imaging of apoptosis in vivo using a modified firefly luciferase substrate, Z-DEVD-aminoluciferin  Academic Article
• Novel Treatments for Multiple Myeloma: What Role Do They Have in Older Adults?  Academic Article
• Novel anticoagulant agents: introduction  Academic Article
• Novel method for differentiation between Trastuzumab and host adaptive response  Academic Article
• Novel strategies for systemic treatment of endometrial cancer  Academic Article
• Novel targets and approaches in advanced prostate cancer  Academic Article
• Nucleotide excision repair in the human ovarian carcinoma cell line (2008) and its cisplatin-resistant variant (C13*)  Academic Article
• Nutritional status of children during treatment for acute lymphoblastic leukemia in Guatemala  Academic Article
• Obstacles to effective Toll-like receptor agonist therapy for hematologic malignancies  Academic Article
• Oligonucleotide degradation contributes to resistance to antisense compounds  Academic Article
• Omics Underpins Novel Clues on VDR Chemoprevention Target in Breast Cancer  Academic Article
• On the receiving end V: Patient perceptions of the side effects of cancer chemotherapy in 1993  Academic Article
• Oncofertility  Academic Article
• Oncostatin M Induces Bone Loss and Sensitizes Rat Osteosarcoma to the Antitumor Effect of MidostaurinIn vivo  Academic Article
• Oncostatin M in combination with tumor necrosis factor ? induces cartilage damage and matrix metalloproteinase expression in vitro and in vivo  Academic Article
• Open-label comparison of the antiemetic efficacy of single intravenous doses of dolasetron mesylate in pediatric cancer patients receiving moderately to highly emetogenic chemotherapy  Academic Article
• Opioids and Dose-Related Deaths—Association or Causation?  Academic Article
• Optic pathway gliomas in adolescence--time to challenge treatment choices?  Academic Article
• Optimizing the Delivery of Targeted Research: An Opportunity for Comparative Effectiveness Research  Academic Article
• Osimertinib in UntreatedEGFR-Mutated Advanced Non–Small-Cell Lung Cancer  Academic Article
• Osteonecrosis in children and adolescents with cancer – An adverse effect of systemic therapy  Academic Article
• Osteopenia in children with acute lymphoblastic leukemia: A pilot study of amelioration with pamidronate  Academic Article
• Outcomes in patients with advanced urothelial carcinoma after discontinuation of programmed death (PD)-1 or PD ligand 1 inhibitor therapy  Academic Article
• Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC  Academic Article
• Overview of phase I studies of intravenous administration of PV701, an oncolytic virus.  Academic Article
• Palbociclib in hormone receptor positive advanced breast cancer: A cost-utility analysis  Academic Article
• Pancratistatin induces apoptosis and autophagy in metastatic prostate cancer cells  Academic Article
• Paraneoplastic Polyarthritis in Hepatocellular Carcinoma Treated With Lenvatinib  Academic Article
• Patient Eligibility and Trial Design for the Salvage Therapy of Advanced Urothelial Carcinoma  Academic Article
• Pattern of carboplatin-induced emesis  Academic Article
• Pediatric oncology sedation trial (POST): A double-blind randomized study  Academic Article
• Pentostatin-induced hypereosinophilia with eosinophilic gastroenteritis  Academic Article
• Perceived cognitive impairment in people with colorectal cancer who do and do not receive chemotherapy  Academic Article
• Personalizing the Treatment of Pediatric Medulloblastoma: Polo-like Kinase 1 as a Molecular Target in High-Risk Children  Academic Article
• Pharmacotherapeutic management of asthma in pregnancy and the effect of sex hormones  Academic Article
• Phase 2 Study of Acupuncture-Like Transcutaneous Nerve Stimulation for Chemotherapy-Induced Peripheral Neuropathy  Academic Article
• Phase I Dose-Escalation Study of Linsitinib (OSI-906) and Erlotinib in Patients with Advanced Solid Tumors  Academic Article
• Phase I clinical, pharmacokinetic and pharmacodynamic study of SB939, an oral histone deacetylase (HDAC) inhibitor, in patients with advanced solid tumours  Academic Article
• Phase I dose-escalation study to determine the safety, pharmacokinetics and pharmacodynamics of brivanib alaninate in combination with full-dose cetuximab in patients with advanced gastrointestinal malignancies who have failed prior therapy  Academic Article
• Phase I trial of UCN-01 in combination with topotecan in patients with advanced solid cancers: a Princess Margaret Hospital Phase II Consortium study  Academic Article
• Phase I trial of lonidamine with whole body hyperthermia in advanced cancer.  Academic Article
• Phase I/II study of the deacetylase inhibitor panobinostat after allogeneic stem cell transplantation in patients with high-risk MDS or AML (PANOBEST trial)  Academic Article
• Phase II Stopping Rules That Employ Response Rates and Early Progression  Academic Article
• Phase II Study of Erlotinib in Recurrent or Metastatic Endometrial Cancer: NCIC IND-148  Academic Article
• Phase II Study of Temsirolimus in Women With Recurrent or Metastatic Endometrial Cancer: A Trial of the NCIC Clinical Trials Group  Academic Article
• Phase II Study of Trimetrexate in Recurrent Anaplastic Glioma: National Cancer Institute of Canada Clinical Trials Group Study  Academic Article
• Phase II Trial of N,N-Diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine.HCl and Doxorubicin Chemotherapy in Metastatic Breast Cancer: A National Cancer Institute of Canada Clinical Trials Group Study  Academic Article
• Phase II Trial of Sorafenib in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck or Nasopharyngeal Carcinoma  Conference Paper
• Phase II study of TAS ‐106 in patients with platinum‐failure recurrent or metastatic head and neck cancer and nasopharyngeal cancer  Academic Article
• Phase II study of CGP 69846A (ISIS 5132) in recurrent epithelial ovarian cancer: an NCIC clinical trials group study (NCIC IND.116)☆  Academic Article
• Phase II study of Triapine® in patients with metastatic renal cell carcinoma: a trial of the National Cancer Institute of Canada Clinical Trials Group (NCIC IND.161)  Academic Article
• Phase II study of erlotinib (OSI-774) in patients with metastatic colorectal cancer  Academic Article
• Phase II study of ispinesib in recurrent or metastatic squamous cell carcinoma of the head and neck  Conference Paper
• Phase II study of lonidamine in patients with metastatic breast cancer: a National Cancer Institute of Canada Clinical Trials Group Study.  Academic Article
• Phase II study of oral menogaril as first line chemotherapy for advanced breast cancer: A National Cancer Institute of Canada Clinical Trials Group Study  Academic Article
• Phase II study of oral ridaforolimus in women with recurrent or metastatic endometrial cancer  Academic Article
• Phase II study of subcutaneous rHu-interleukin-2 and rHu-interferon α-2a in previously treated patients with multiple myeloma  Academic Article
• Phase II study of temsirolimus (CCI-779) in women with recurrent, unresectable, locally advanced or metastatic carcinoma of the cervix. A trial of the NCIC Clinical Trials Group (NCIC CTG IND 199)  Academic Article
• Phase II study of the progesterone antagonist mifepristone in patients with untreated metastatic breast carcinoma: a National Cancer Institute of Canada Clinical Trials Group study.  Academic Article
• Phase II trial of flavopiridol, a cyclin dependent kinase inhibitor, in untreated metastatic malignant melanoma  Academic Article
• Phase II trial of vorinostat in advanced melanoma  Academic Article
• Phase III trial comparing radical radiotherapy with and without cisplatin chemotherapy in patients with advanced squamous cell cancer of the cervix.  Academic Article
• Phase III trial to evaluate the efficacy of maintaining hemoglobin levels above 12.0 g/dL with erythropoietin vs above 10.0 g/dL without erythropoietin in anemic patients receiving concurrent radiation and cisplatin for cervical cancer  Academic Article
• Phosphopeptide Selective Coordination Complexes as Promising Src Homology 2 Domain Mimetics  Academic Article
• Photobleaching kinetics of Photofrinin vivoand in multicell tumour spheroids indicate two simultaneous bleaching mechanisms  Academic Article
• Photodynamic therapy using Photofrin in combination with buthionine sulfoximine (BSO) to treat 9L gliosarcoma in rat brain  Academic Article
• Physician/Patient Decision Aids for Adjuvant Therapy  Academic Article
• Pin1 Links the Activities of c-Abl and p300 in Regulating p73 Function  Academic Article
• Plant-Produced Trastuzumab Inhibits the Growth of HER2 Positive Cancer Cells  Academic Article
• Pneumatosis Intestinalis and Bowel Perforation Associated With Molecular Targeted Therapy: An Emerging Problem and the Role of Radiologists in Its Management  Academic Article
• Point/counterpoint: early-stage Hodgkin lymphoma and the role of radiation therapy.  Academic Article
• Pointed Progress in Second-Line Advanced Non–Small-Cell Lung Cancer: The Rapidly Evolving Field of Checkpoint Inhibition  Academic Article
• Poly(ethylene glycol) induces cell toxicity in melanoma cells by producing a hyperosmotic extracellular medium  Academic Article
• Population-Based Study to Determine the Health System Costs of Using the 21-Gene Assay  Academic Article
• Predicting Anthracycline Benefit: TOP2A and CEP17—Not Only but Also  Academic Article
• Predicting Teratoma in the Retroperitoneum in Men Undergoing Post-Chemotherapy Retroperitoneal Lymph Node Dissection  Academic Article
• Predicting fever in neutropenia with safety‐relevant events in children undergoing chemotherapy for cancer: The prospective multicenter SPOG 2015 FN Definition Study  Academic Article
• Predicting response to EGFR-tyrosine kinase inhibitors among diverse ancestries: Just way too polymorphic  Academic Article
• Prediction of Late Disease Recurrence and Extended Adjuvant Letrozole Benefit by the HOXB13/IL17BR Biomarker  Academic Article
• Preferential Killing of Breast Tumor Initiating Cells by N,N-Diethyl-2-[4-(Phenylmethyl)Phenoxy]Ethanamine/Tesmilifene  Academic Article
• Prevention and treatment of anticipatory chemotherapy‐induced nausea and vomiting in pediatric cancer patients and hematopoietic stem cell recipients: Clinical practice guideline update  Academic Article
• Prevention of Thrombosis in Ambulatory Patients With Cancer  Academic Article
• Prevention of Thrombotic Disorders in Cancer Patients Undergoing Chemotherapy  Academic Article
• Prevention of acute and delayed chemotherapy‐induced nausea and vomiting in pediatric cancer patients: A clinical practice guideline  Academic Article
• Primary tumor and patient characteristics in breast cancer as predictors of adjuvant therapy regimen: a regression model  Academic Article
• Prognosis of older patients with newly diagnosed AML undergoing antileukemic therapy: A systematic review  Academic Article
• Prognostic Factors in the Radical Nonsurgical Treatment of Stage IIIB Non–Small-Cell Lung Cancer  Academic Article
• Prolonged complete remission in two cases of acute promyelocytic leukaemia treated with atra alone  Academic Article
• Prospective evaluation of pretreatment and intratreatment FDG PET‐CT SUV stability in primary head and neck cancer  Academic Article
• Proteasome Inhibition With Bortezomib (PS-341): A Phase I Study With Pharmacodynamic End Points Using a Day 1 and Day 4 Schedule in a 14-Day Cycle  Academic Article
• Protumorigenic effects of mir-145 loss in malignant pleural mesothelioma  Academic Article
• Pyrimethamine as a Potent and Selective Inhibitor of Acute Myeloid Leukemia Identified by High-throughput Drug Screening  Academic Article
• Pyrvinium Targets CD133 in Human Glioblastoma Brain Tumor–Initiating Cells  Academic Article
• Quality Improvement Guidelines for Transarterial Chemoembolization and Embolization of Hepatic Malignancy  Academic Article
• Quality of Life in a Prospective, Multicenter Phase 2 Trial of Neoadjuvant Full-Dose Gemcitabine, Oxaliplatin, and Radiation in Patients With Resectable or Borderline Resectable Pancreatic Adenocarcinoma  Academic Article
• Quality of life and swallowing with standard chemoradiotherapy versus accelerated radiotherapy and panitumumab in locoregionally advanced carcinoma of the head and neck: A phase III randomised trial from the Canadian Cancer Trials Group (HN.6)  Academic Article
• Quality of life in stage II breast cancer: an instrument for clinical trials.  Academic Article
• Quality-adjusted life years was a poor predictor of women's willingness to pay in acute and chronic conditions: results of a survey  Academic Article
• Quality-adjusted time without symptoms or toxicity analysis of interferon maintenance in multiple myeloma.  Academic Article
• Quality-of-Life Measurement in Randomized Clinical Trials in Breast Cancer: An Updated Systematic Review (2001–2009)  Academic Article
• Quantification of matrix metalloproteinase activity in plasma of patients enrolled in a BAY 12-9566 phase I study  Academic Article
• Quantitative evaluation of single-arm versus randomized phase II cancer clinical trials  Academic Article
• Quantitative ultrasound assessment of breast tumor response to chemotherapy using a multi-parameter approach  Academic Article
• Quinolone-Based Antibacterial Chemoprophylaxis in Neutropenic Patients: Effect of Augmented Gram-Positive Activity on Infectious Morbidity  Academic Article
• Quizartinib for the treatment of acute myeloid leukemia  Academic Article
• Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck  Academic Article
• Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival  Academic Article
• Raloxifene, a Mixed Estrogen Agonist/Antagonist, Induces Apoptosis through Cleavage of BAD in TSU-PR1 Human Cancer Cells  Academic Article
• Randomized Phase II Study Comparing Two Schedules of Everolimus in Patients With Recurrent/Metastatic Breast Cancer: NCIC Clinical Trials Group IND.163  Conference Paper
• Randomized Trial of a Telephone-Based Weight Loss Intervention in Postmenopausal Women With Breast Cancer Receiving Letrozole: The LISA Trial  Academic Article
• Randomized Trials in Oncology Stopped Early for Benefit  Academic Article
• Randomized window of opportunity trial evaluating high-dose vitamin D in breast cancer patients  Academic Article
• Rash in four patients with brain tumor-related epilepsy in monotherapy with oxcarbazepine, during radiotherapy  Academic Article
• Real-World Use of Trifluridine/Tipiracil for Patients with Metastatic Colorectal Cancer in Canada  Academic Article
• Recent developments in the clinical pharmacology of rolapitant: subanalyses in specific populations  Academic Article
• Recommendations for ototoxicity surveillance for childhood, adolescent, and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCare Consortium  Academic Article
• Reduced Morbidity Following Cytoreductive Surgery and Intraperitoneal Hyperthermic Chemoperfusion  Conference Paper
• Reduced tissue macrophage population in the lung by anticancer agent cyclophosphamide: restoration by local granulocyte macrophage–colony-stimulating factor gene transfer  Academic Article
• Refinement of the Symptom Screening in Pediatrics Tool (SSPedi)  Academic Article
• Regional Nodal Irradiation in Early-Stage Breast Cancer  Academic Article
• Relevant clinical end points in biphosphonate trials.  Academic Article
• Renal failure among multiple myeloma patients utilizing carfilzomib and associated factors in the “real world”  Academic Article
• Researching the Cost of Research  Academic Article
• Response to Suissa and Azoulay. The Association of Basal Insulin Glargine and/or n-3 Fatty Acids With Incident Cancers in Patients With Dysglycemia. Diabetes Care 2014;37:1360–1366  Academic Article
• Response to Zanders et al. The Association of Basal Insulin Glargine and/or n-3 Fatty Acids With Incident Cancers in Patients With Dysglycemia. Diabetes Care 2014;37:1360–1366  Academic Article
• Results of the SEL-I-METRY Phase II Trial on Resensitization of Advanced Iodine Refractory Differentiated Thyroid Cancer to Radioiodine Therapy  Academic Article
• Retinoic acid and arsenic trioxide sensitize acute promyelocytic leukemia cells to ER stress  Academic Article
• Review of Cytotoxic CA4 Analogues that Do Not Target Microtubules: Implications for CA4 Development.  Academic Article
• Review of second-line chemotherapy for advanced gastric adenocarcinoma  Academic Article
• Ribbon of DNA Lattice on Gold Nanoparticles for Selective Drug Delivery to Cancer Cells  Academic Article
• Risk factors for survival following recurrence after first liver resection for colorectal cancer liver metastases  Academic Article
• Risk of Thrombosis With Lenalidomide and Its Prevention With Aspirin  Academic Article
• Risk of chemotherapy induced menopause: More detailed data will lead to improved quality of life  Academic Article
• Rituximab in Lymphoma and Chronic Lymphocytic Leukaemia: A Practice Guideline  Academic Article
• Rituximab in lymphoma: A systematic review and consensus practice guideline from Cancer Care Ontario  Academic Article
• Rituximab maintenance for relapsed refractory thrombotic thrombocytopenic purpura  Academic Article
• Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer  Academic Article
• Robot-assisted Versus Open Radical Cystectomy in Patients Receiving Perioperative Chemotherapy for Muscle-invasive Bladder Cancer: The Oncologist’s Perspective from a Multicentre Study  Academic Article
• Rodlike Particles of Polydopamine-CdTe Quantum Dots: An Actuator As a Photothermal Agent and Reactive Oxygen Species-Generating Nanoplatform for Cancer Therapy  Academic Article
• Rolapitant for the treatment of chemotherapy-induced nausea and vomiting: a review of the clinical evidence  Academic Article
• Role of KRAS and EGFR As Biomarkers of Response to Erlotinib in National Cancer Institute of Canada Clinical Trials Group Study BR.21  Academic Article
• Role of the transcription factor Ets-1 in cisplatin resistance  Academic Article
• Safety and Efficacy of Patupilone in Patients With Advanced Ovarian, Primary Fallopian, or Primary Peritoneal Cancer: A Phase I, Open-Label, Dose-Escalation Study  Academic Article
• Safety and Efficacy of Sorafenib in Elderly Patients Treated in the North American Advanced Renal Cell Carcinoma Sorafenib Expanded Access Program  Academic Article
• Safety and efficacy findings from the open-label, multicenter, phase 3b, expanded treatment protocol study of ruxolitinib for treatment of patients with polycythemia vera who are resistant/intolerant to hydroxyurea and for whom no alternative treatments are available  Academic Article
• Safety and efficacy of different lenalidomide starting doses in patients with relapsed or refractory chronic lymphocytic leukemia: results of an international multicenter double-blinded randomized phase II trial*  Academic Article
• Safety and efficacy results of the advanced renal cell carcinoma sorafenib expanded access program in North America  Academic Article
• Safety of Treatment of Metastatic Breast Cancer With Trastuzumab Beyond Disease Progression  Academic Article
• Safety of enzalutamide in patients with metastatic castration‐resistant prostate cancer previously treated with docetaxel: Expanded access in North America  Academic Article
• Safety, Pharmacokinetics, and Preliminary Antitumor Activity of Sorafenib: A Review of Four Phase I Trials in Patients with Advanced Refractory Solid Tumors  Academic Article
• Sample size and power issues in estimating incremental cost-effectiveness ratios from clinical trials data  Academic Article
• Second-Line Treatment of Non-Small Cell Lung Cancer: New Developments for Tumours Not Harbouring Targetable Oncogenic Driver Mutations  Academic Article
• Second‐line treatment of hepatocellular carcinoma after sorafenib: Characterizing treatments used over the past 10 years and real‐world eligibility for cabozantinib, regorafenib, and ramucirumab  Academic Article
• Semuloparin for Thromboprophylaxis in Patients Receiving Chemotherapy for Cancer  Academic Article
• Sequential preoperative fluorodeoxyglucose-positron emission tomography assessment of response to preoperative chemoradiation: a means for determining longterm outcomes of rectal cancer1  Conference Paper
• Serotonergic system antagonists target breast tumor initiating cells and synergize with chemotherapy to shrink human breast tumor xenografts  Academic Article
• Single pivotal trials with few corroborating characteristics were used for FDA approval of cancer therapies  Academic Article
• Single-center experience with radium-223 in patients with castration-resistant prostate cancer and bone metastases  Academic Article
• Skeletal Muscle Depletion Is Associated with Reduced Plasma (n-3) Fatty Acids in Non-Small Cell Lung Cancer Patients  Academic Article
• Small Structural Differences between Two Ferrocenyl Diphenols Determine Large Discrepancies of Reactivity and Biological Effects  Academic Article
• Soft-Tissue Necrosis Induced by Extravasated Cancer Chemotherapeutic Agents2, 3  Academic Article
• Sorafenib Maintenance After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia With FLT3–Internal Tandem Duplication Mutation (SORMAIN)  Academic Article
• Sorafenib and Radiation Therapy for the Treatment of Advanced Hepatocellular Carcinoma  Academic Article
• Species Specificity of Amidine-Based Urokinase Inhibitors  Academic Article
• Spleen effluent manipulations  Academic Article
• Standard chemotherapy in squamous cell head and neck cancer: what we have learned from randomized trials.  Academic Article
• Statement of the Science Concerning Locoregional Treatments After Preoperative Chemotherapy for Breast Cancer: A National Cancer Institute Conference  Academic Article
• Statin Therapy and Outcomes in Trials of Nintedanib in Idiopathic Pulmonary Fibrosis  Academic Article
• Statin Use and Survival in Patients with Metastatic Castration-resistant Prostate Cancer Treated with Abiraterone Acetate  Academic Article
• Statin therapy in the treatment of active cancer: A systematic review and meta-analysis of randomized controlled trials  Academic Article
• Stopping rules employing response rates, time to progression, and early progressive disease for phase II oncology trials  Academic Article
• Stressproteine bei der Pathogenese des Prostatakarzinoms  Academic Article
• Structurally simplified biphenyl combretastatin A4 derivatives retain in vitro anti-cancer activity dependent on mitotic arrest  Academic Article
• Structure-activity studies on N -Substituted tranylcypromine derivatives lead to selective inhibitors of lysine specific demethylase 1 (LSD1) and potent inducers of leukemic cell differentiation  Academic Article
• Structure–activity studies on seco-pancratistatin analogs: Potent inhibitors of human cytochrome P450 3A4  Academic Article
• Studies with a 2,4-diamino-5-(3',4'-dichlorophenyl)-6-methylpyrimidine (DDMP)-resistant L1210 leukemia cell line without cross-resistance to methotrexate  Academic Article
• Sulfasalazine-induced cystine starvation: Potential use for prostate cancer therapy  Academic Article
• Superantigen immune stimulation activates epithelial STAT-1 and PI 3-K: PI 3-K regulation of permeability  Academic Article
• Superiority of methylprednisolone sodium succinate over low dose metoclopramide hydrochloride in the prevention of nausea and vomiting produced by cancer chemotherapy.  Academic Article
• Surveillance imaging for high‐grade childhood brain tumors: What to do 10 years after completion of treatment?  Academic Article
• Sustained activation of the extracellular signal-regulated kinase pathway protects cells from photofrin-mediated photodynamic therapy.  Academic Article
• Sustained deep molecular responses in patients switched to nilotinib due to persistent BCR-ABL1 on imatinib: final ENESTcmr randomized trial results  Academic Article
• Swelling‐induced chloride current in glioblastoma proliferation, migration, and invasion  Academic Article
• Symptom assessment in children receiving cancer therapy: the parents’ perspective  Academic Article
• Symptom clusters using the Brief Pain Inventory in patients with breast cancer  Academic Article
• Synthesis and Biological Evaluation of Fully Functionalized seco-Pancratistatin Analogues  Academic Article
• Synthesis and Evaluation of Anticancer Natural Product Analogues Based on Angelmarin: Targeting the Tolerance towards Nutrient Deprivation  Academic Article
• Synthesis and characterization of cyclohexane-1R,2R-diamine-based Pt(iv) dicarboxylato anticancer prodrugs: their selective activity against human colon cancer cell lines  Academic Article
• Synthesis and evaluation of new salicylaldehyde-2-picolinylhydrazone Schiff base compounds of Ru(II), Rh(III) and Ir(III) as in vitro antitumor, antibacterial and fluorescence imaging agents  Academic Article
• Synthesis and structure-activity relationships among glycosidic derivatives of 4'-demethylepipodophyllotoxin and epipodophyllotoxin, showing VM26- and VP16-213-like activities.  Academic Article
• Synthesis of Boroxifen, A Nido-Carborane Analogue of Tamoxifen  Academic Article
• Synthesis, characterization, structure, molecular modeling studies and biological activity of sterically crowded Pt(II) complexes containing bis(imidazole) ligands  Academic Article
• Synthesis, oxidation chemistry and cytotoxicity studies on ferrocene derivatives of diethylstilbestrol  Academic Article
• Systemic Therapy for Stage IV Non–Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update  Academic Article
• Systemic adjuvant therapy for node-negative breast cancer.  Academic Article
• Systemic therapy for previously untreated advanced BRAF-mutated melanoma: navigating a shifting landscape  Academic Article
• Systemic treatments for metastatic urothelial carcinoma  Academic Article
• TLE3 is not a predictive biomarker for taxane sensitivity in the NCIC CTG MA.21 clinical trial  Academic Article
• Targeted Drug Delivery Using a Plug-to-Direct Antibody–Nanogel Conjugate  Academic Article
• Targeted and Non-Targeted Mechanisms for Killing Hypoxic Tumour Cells—Are There New Avenues for Treatment?  Academic Article
• Targeted radionuclide therapy in combined-modality regimens  Academic Article
• Targeted therapy for metastatic renal cell carcinoma  Academic Article
• Targeting SUMOylation dependency in human cancer stem cells through a unique SAE2 motif revealed by chemical genomics  Academic Article
• Targeting endothelin 1 receptor-miR-200b/c-ZEB1 circuitry blunts metastatic progression in ovarian cancer  Academic Article
• Targeting prostate cancer with HTI-286, a synthetic analog of the marine sponge product hemiasterlin  Academic Article
• Targeting the epidermal growth factor receptor in non-small-cell lung cancer: Who, which, when, and how?  Academic Article
• Teclistamab in Relapsed or Refractory Multiple Myeloma  Academic Article
• Teclistamab in Relapsed or Refractory Multiple Myeloma. Reply.  Academic Article
• Telomerase, Cell Immortality, and Cancer  Academic Article
• The Antiarrhythmic Drug, Dronedarone, Demonstrates Cytotoxic Effects in Breast Cancer Independent of Thyroid Hormone Receptor Alpha 1 (THRα1) Antagonism  Academic Article
• The Association of Basal Insulin Glargine and/or n-3 Fatty Acids With Incident Cancers in Patients With Dysglycemia  Academic Article
• The CANMAT task force recommendations for the management of patients with mood disorders and comorbid medical conditions: diagnostic, assessment, and treatment principles.  Academic Article
• The Cancer-associated K351N Mutation Affects the Ubiquitination and the Translocation to Mitochondria of p53 Protein  Academic Article
• The Completeness of Reporting (CORE) index identifies important deficiencies in observational study conference abstracts  Academic Article
• The Cost-Effectiveness of Lenvatinib in the Treatment of Advanced or Unresectable Hepatocellular Carcinoma from a Canadian Perspective  Academic Article
• The Impact of Chemotherapy-Induced Cognitive Impairment on the Psychosocial Adjustment of Patients With Nonmetastatic Colorectal Cancer  Academic Article
• The Price We Pay for Progress: A Meta-Analysis of Harms of Newly Approved Anticancer Drugs  Academic Article
• The Prognostic Importance of Metastatic Site in Men with Metastatic Castration-resistant Prostate Cancer  Academic Article
• The Silence in Hoch et al.’s Commentary about the Rationale for and Objective(s) of Canada’s Separate HTA Process for Cancer Drugs: The Importance of Transparency and Accountability when Allocating Taxpayers’ Dollars  Academic Article
• The Thrombophilic State Induced by Therapeutic Agents in the Cancer Patient  Academic Article
• The Urgent Need for Clinical Research Reform to Permit Faster, Less Expensive Access to New Therapies for Lethal Diseases  Academic Article
• The Use of Endocrine Therapy  Academic Article
• The Voice of Experience: Diet and Weight Change in Women with Breast Cancer Associate with Psychosocial and Treatment-Related Challenges  Academic Article
• The arotinoids: early clinical experience and discussion of future development.  Academic Article
• The association between radiographic response and overall survival in men with metastatic castration-resistant prostate cancer receiving chemotherapy  Academic Article
• The chemotherapy metabolite acrolein upregulates thrombin generation and impairs the protein C anticoagulant pathway in animal‐based and cell‐based models  Academic Article
• The current role of anti-emetic drugs in oncology: a recent revolution in patient symptom control  Academic Article
• The disruption of the protein complex mutantp53/p73 increases selectively the response of tumor cells to anticancer drugs  Academic Article
• The effects of chemotherapeutic agents on the regulation of thrombin on cell surfaces  Academic Article
• The efficacy and safety of sunitinib given on an individualised schedule as first-line therapy for metastatic renal cell carcinoma: A phase 2 clinical trial  Academic Article
• The emerging treatment landscape of advanced urothelial carcinoma  Academic Article
• The enzyme-sensitive release of prodigiosin grafted β-cyclodextrin and chitosan magnetic nanoparticles as an anticancer drug delivery system: Synthesis, characterization and cytotoxicity studies  Academic Article
• The impact of an educational DVD on cancer patients considering participation in a phase I clinical trial  Academic Article
• The impact of postchemotherapy nausea and vomiting on quality of life after moderately emetogenic chemotherapy  Academic Article
• The impact of ruxolitinib on thrombosis in patients with polycythemia vera and myelofibrosis  Academic Article
• The international scandal of defective asparaginase: A blight on children with cancer  Academic Article
• The low incidence of secondary acute myelogenous leukaemia in children and adolescents treated with dexrazoxane for acute lymphoblastic leukaemia: A report from the Dana-Farber Cancer Institute ALL Consortium  Academic Article
• The oncolytic adenovirus AdΔΔ enhances selective cancer cell killing in combination with DNA-damaging drugs in pancreatic cancer models  Academic Article
• The peroxisome proliferator-activated receptor γ agonist pioglitazone prevents NF-κB activation in cisplatin nephrotoxicity through the reduction of p65 acetylation via the AMPK-SIRT1/p300 pathway  Academic Article
• The role of dose intensity in determining outcome in intermediate-grade non-Hodgkin's lymphoma.  Academic Article
• The treatment of acute myelocytic leukemia in patients 30 years of age and younger  Academic Article
• The triponderal mass index as a measure of adiposity in pediatric survivors of acute lymphoblastic leukemia: a cross-sectional study  Academic Article
• Therapeutic Options for Neuroendocrine Tumors  Academic Article
• Therapy for relapsed multiple myeloma  Academic Article
• Thiazolidinedione drugs down-regulate CXCR4 expression on human colorectal cancer cells in a peroxisome proliferator activated receptor γ-dependent manner  Academic Article
• Thromboembolic events in patients with urothelial carcinoma undergoing neoadjuvant chemotherapy and radical cystectomy  Academic Article
• Thrombosis and cancer: implications beyond Trousseau  Academic Article
• Thrombosis in children with acute lymphoblastic leukemia  Academic Article
• Tolerability and efficacy of docetaxel in older men with metastatic castrate-resistant prostate cancer (mCRPC) in the TAX 327 trial  Academic Article
• Transformation of the Anticancer Drug Doxorubicin in the Human Gut Microbiome  Academic Article
• Transfusion-related alloimmunization in children: epidemiology and effects of chemotherapy  Academic Article
• Trastuzumab Cardiac Side Effects: Only Time Will Tell  Academic Article
• Treatment and Clinical Outcomes of Patients with Teratoma with Somatic-Type Malignant Transformation: An International Collaboration  Academic Article
• Treatment of Hormone-Refractory Prostate Cancer with Docetaxel or Mitoxantrone: Relationships between Prostate-Specific Antigen, Pain, and Quality of Life Response and Survival in the TAX-327 Study  Academic Article
• Treatment of breakthrough and prevention of refractory chemotherapy‐induced nausea and vomiting in pediatric cancer patients: Clinical practice guideline update  Academic Article
• Treatment of estrogen deficiency symptoms in women surviving breast cancer. Part 2: Hormone replacement therapy and breast cancer.  Academic Article
• Treatment of estrogen deficiency symptoms in women surviving breast cancer. Part 5: Selective estrogen receptor modulators and hormone replacement therapy. Proceedings of a conference. Charlottesville, Virginia, USA. September 21-23, 1997.  Conference Paper
• Treatment of mCRPC in the AR-axis-targeted therapy-resistant state  Conference Paper
• Treatment with trastuzumab for 1 year after adjuvant chemotherapy in patients with HER2-positive early breast cancer: a 4-year follow-up of a randomised controlled trial  Academic Article
• Treatment-induced cell cycle kinetics dictate tumor response to chemotherapy  Academic Article
• Truncated ring-A amaryllidaceae alkaloid modulates the host cell integrated stress response, exhibiting antiviral activity to HSV-1 and SARSCoV-2  Academic Article
• USP2a alters chemotherapeutic response by modulating redox  Academic Article
• Ultrasound Imaging of Apoptosis: Spectroscopic Detection of DNA-Damage Effects In Vivo  Academic Article
• Unresected stage III non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group.  Academic Article
• Up-regulation of PK11195 binding in areas of axonal degeneration coincides with early microglial activation in mouse brain  Academic Article
• Up-to-date approach to manage keloids and hypertrophic scars: A useful guide  Academic Article
• Upper Tract Urothelial Carcinomas: Prognostic Factors and Outcomes in Patients With Non–Lymph Node Distant Metastasis  Academic Article
• Urothelial Bladder Cancer with Cavitary Lung Metastases  Academic Article
• Use of ErbB-1 and ErbB-2 to Select Endocrine Therapy for Breast Cancer: Will It Play in Peoria?  Academic Article
• Use of dexamethasone and granisetron in the control of delayed emesis for patients who receive highly emetogenic chemotherapy. National Cancer Institute of Canada Clinical Trials Group.  Academic Article
• Use of granulocyte colony-stimulating factor (G-CSF) in patients receiving myelosuppressive chemotherapy for the treatment of cancer. Provincial Systemic Treatment Disease Site Group.  Academic Article
• Using bevacizumab to treat metastatic cancer: UK consensus guidelines  Academic Article
• Utility of peripheral blood cultures in bacteremic pediatric cancer patients with a central line  Academic Article
• Value assessment of oncology drugs using a weighted criterion‐based approach  Academic Article
• Variation in the Association between Antineoplastic Therapies and Venous Thromboembolism in Patients with Active Cancer  Academic Article
• Veliparib in Combination with Carboplatin and Etoposide in Patients with Treatment-Naïve Extensive-Stage Small Cell Lung Cancer: A Phase 2 Randomized Study  Academic Article
• Venetoclax for the treatment of translocation (11;14) AL amyloidosis  Academic Article
• Venous Thromboembolism in Malignancy and Malignancy in Venous Thromboembolism  Academic Article
• Very low-quality evidence suggests that aloe vera could have benefits in preventing chemotherapy-induced oral mucositis in children compared with sodium bicarbonate  Academic Article
• Vinblastine-Induced Erythrocytotoxicity  Academic Article
• Weekly Cyclophosphamide and Alternate-Day Prednisone: An Effective, Convenient, and Well-Tolerated Oral Treatment for Relapsed Multiple Myeloma After Autologous Stem Cell Transplantation  Academic Article
• Zoledronic acid is superior to pamidronate for the treatment of bone metastases in breast carcinoma patients with at least one osteolytic lesion  Academic Article
• [ ¹⁸ F]CFA as a clinically translatable probe for PET imaging of deoxycytidine kinase activity  Academic Article
• miR-204 targets Bcl-2 expression and enhances responsiveness of gastric cancer  Academic Article
• p73-Mediated Chemosensitivity: A Preferential Target of Oncogenic Mutant p53  Academic Article
• β-arrestin1/YAP/mutant p53 complexes orchestrate the endothelin A receptor signaling in high-grade serous ovarian cancer  Academic Article
• “There is always a better way”: Managing uncertainty in decision making about new cancer drugs in Canada  Academic Article